ASCENDIS PHARMA
Ascendis Pharma has built a high value pipeline with the aim of changing clinical treatment paradigms. Using our innovative TransCon prodrug technology platform, we continue to identify new opportunities addressing areas of high unmet medical need. TransCon is applicable to all drug classes, and is currently being used to create superior prodrugs of proteins, peptides and small molecules. Depending on choice of TransCon Carrier, either systemic or localized drug exposure is achieved, while dosin... g frequency is determined by the choice of TransCon Linker. The prodrugs are new chemical entities with new patent life. Product development process is de-risked, as the prodrugs release the active component in its native and unmodified form, maintaining the original drug’s well known mode of action.
ASCENDIS PHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2006-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.ascendispharma.com
Total Employee:
251+
Status:
Active
Contact:
650 352 8389
Email Addresses:
[email protected]
Total Funding:
585.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Carebox Healthcare
Carebox connects patients and physicians exploring treatment options with clinical trials.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-12-13 | Complex Biosystems | Complex Biosystems acquired by Ascendis Pharma | N/A |
Investors List
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Ascendis Pharma
Venrock
Venrock investment in Series D - Ascendis Pharma
Sofinnova Investments
Sofinnova Investments investment in Series D - Ascendis Pharma
Rock Springs Capital
Rock Springs Capital investment in Series D - Ascendis Pharma
RA Capital Management
RA Capital Management investment in Series D - Ascendis Pharma
OrbiMed
OrbiMed investment in Series D - Ascendis Pharma
Vivo Capital
Vivo Capital investment in Series D - Ascendis Pharma
Gilde Healthcare
Gilde Healthcare investment in Series A - Ascendis Pharma
TechnoStart
TechnoStart investment in Series A - Ascendis Pharma
Sofinnova Partners
Sofinnova Partners investment in Series A - Ascendis Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-01-08 | Visen Pharmaceuticals | Ascendis Pharma investment in Series B - Visen Pharmaceuticals | 150 M USD |
| 2018-11-13 | Visen Pharmaceuticals | Ascendis Pharma investment in Series A - Visen Pharmaceuticals | 40 M USD |
Official Site Inspections
http://www.ascendispharma.com Semrush global rank: 2.31 M Semrush visits lastest month: 8.09 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
